Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
New Chemistry for Old-Targets: a novel platform for non-tuberculous mycobacteria drug discovery
EF 2017-18
Résumé
Antibiotic resistance has spread across many species of bacteria where some have acquired resistance more readily than others, namely non-tuberculous mycobacteria (NTM). NTM are the lesser known but closely-related species of Mycobacterium tuberculosis , the causative agent of tuberculosis (TB). In fact, NTM do cause TB-like diseases, yet have been overlooked as far as requiring novel antibiotic therapies. As a result, we have an abundance of patients with NTM infections that have little to no therapy options available. Unfortunately, the drug discovery pipeline for therapies against mycobacteria has dwindled recently due to their slow-growing nature, where screening techniques and validation took years of laborious experiments.In this study, we aim to develop new therapies for patients with NTM infections by developing, and then employing, a novel screening method. We hypothesize that new therapeutics may be discovered using structural biology and chemistry to 1) develop an innovative screening platform using bioluminescence resonance energy transfer (NanoBRET), and 2) partner this platform with modifications of antibiotics on the market.First, we will design and validate NanoBRET in an E. coli model to demonstrate feasibility. Second, we will use NanoBRET to screen for chemically modified analogs of antibiotics previously designed by collaborators at the Structure-guided Drug Discovery Coalition in the relevant NTM species.We believe the unconventional approach of this project will help reinvigorate and contribute to antibiotic discovery, specifically towards NTM infections, by providing a novel platform for screening chemical compounds and highlighting new antimicrobials.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386451
Name
Sullivan Jaryd R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
New Chemistry for Old-Targets: a novel platform for non-tuberculous mycobacteria drug discovery
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Drug Discovery; Efflux Inhibitors; Infectious Diseases; Molecular Biology; Mycobacterium Abscessus; Mycobacterium Avium; Nanobret; Therapeutics
Abstract
Antibiotic resistance has spread across many species of bacteria where some have acquired resistance more readily than others, namely non-tuberculous mycobacteria (NTM). NTM are the lesser known but closely-related species of Mycobacterium tuberculosis , the causative agent of tuberculosis (TB). In fact, NTM do cause TB-like diseases, yet have been overlooked as far as requiring novel antibiotic therapies. As a result, we have an abundance of patients with NTM infections that have little to no therapy options available. Unfortunately, the drug discovery pipeline for therapies against mycobacteria has dwindled recently due to their slow-growing nature, where screening techniques and validation took years of laborious experiments.In this study, we aim to develop new therapies for patients with NTM infections by developing, and then employing, a novel screening method. We hypothesize that new therapeutics may be discovered using structural biology and chemistry to 1) develop an innovative screening platform using bioluminescence resonance energy transfer (NanoBRET), and 2) partner this platform with modifications of antibiotics on the market.First, we will design and validate NanoBRET in an E. coli model to demonstrate feasibility. Second, we will use NanoBRET to screen for chemically modified analogs of antibiotics previously designed by collaborators at the Structure-guided Drug Discovery Coalition in the relevant NTM species.We believe the unconventional approach of this project will help reinvigorate and contribute to antibiotic discovery, specifically towards NTM infections, by providing a novel platform for screening chemical compounds and highlighting new antimicrobials.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sullivan, Jaryd R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~